These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21132551)

  • 41. Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.
    Vastert SJ; Prakken BJ
    Nat Rev Rheumatol; 2014 Nov; 10(11):640-2. PubMed ID: 25201384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran.
    Assari R; Sadeghi P; Mirmohammadsadeghi A; Ebadi F; Ziaee V
    Reumatismo; 2020 Jan; 71(4):189-198. PubMed ID: 31995957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
    Ann Rheum Dis; 2016 Mar; 75(3):481-9. PubMed ID: 26865703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease.
    Erkens R; Esteban Y; Towe C; Schulert G; Vastert S
    Rheum Dis Clin North Am; 2021 Nov; 47(4):585-606. PubMed ID: 34635293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of serum ferritin in measuring the activation and prognosis in systemic onset juvenile idiopathic arthritis].
    Zhou YF; Li CF; Wang J; Han TX; Kuang WY; Deng JH; Zhang JM; Tan XH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2487-9. PubMed ID: 24300271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome.
    Kinjo N; Hamada K; Hirayama C; Shimizu M
    J Clin Apher; 2018 Feb; 33(1):117-120. PubMed ID: 28730667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review.
    Jiang H; Yang Z
    Front Pediatr; 2020; 8():93. PubMed ID: 32211357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Splenomegaly in Kawasaki Disease: A Pitfall in Diagnosis.
    Miselli F; Mastrolia MV; Simonini G; Trapani S; Calabri GB
    J Pediatr; 2023 Jun; 257():113359. PubMed ID: 36813130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review.
    García-Pavón S; Yamazaki-Nakashimada MA; Báez M; Borjas-Aguilar KL; Murata C
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):445-451. PubMed ID: 28562511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Kawasaki disease with severe manifestations and macrophage activation syndrome in a pediatric patient].
    Vélez-Tirado N; López G; Mijail Chío I; Gutiérrez Hernández A
    Arch Argent Pediatr; 2019 Dec; 117(6):e676-e678. PubMed ID: 31758909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of disease course in systemic juvenile idiopathic arthritis.
    Kaplan MM; Ekici Tekin Z; Çelikel E; Güngörer V; Karagöl C; Öner N; Polat MC; Öztürk D; Özçelik E; Işıklar Ekici M; Çelikel Acar B
    Mod Rheumatol; 2024 Oct; 34(6):1238-1245. PubMed ID: 38590038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis.
    Shimizu M; Mizuta M; Yasumi T; Iwata N; Okura Y; Kinjo N; Umebayashi H; Kubota T; Nakagishi Y; Nishimura K; Yashiro M; Yasumura J; Yamazaki K; Wakiguchi H; Okamoto N; Mori M
    Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1412-1415. PubMed ID: 29195002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PRECORDIAL PAIN, LEUKOCYTOSIS AND BICYTOPENIA IN A TEENAGER WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS UNDER IMMUNOSUPPRESSIVE THERAPY.
    Vieira MS; Andrade FR; Brandão LMKR; Nóbrega VTD; Guissa VR; Provenza JR
    Rev Paul Pediatr; 2019; 37(2):252-256. PubMed ID: 30810692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
    Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
    Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage activation syndrome in Kawasaki disease: more common than we thought?
    Wang W; Gong F; Zhu W; Fu S; Zhang Q
    Semin Arthritis Rheum; 2015 Feb; 44(4):405-10. PubMed ID: 25200945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophage activation syndrome in the acute phase of Kawasaki disease.
    Latino GA; Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):527-31. PubMed ID: 20485197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis.
    Félix FH; Leal LK; Fontenele JB
    Rheumatol Int; 2009 Jun; 29(8):973-4. PubMed ID: 19115058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Minoia F; Davì S; Horne A; Bovis F; Demirkaya E; Akikusa J; Ayaz NA; Al-Mayouf SM; Barone P; Bica B; Bolt I; Breda L; De Cunto C; Enciso S; Gallizzi R; Griffin T; Hennon T; Horneff G; Jeng M; Kapovic AM; Lipton JM; Magni Manzoni S; Rumba-Rozenfelde I; Magalhaes CS; Sewairi WM; Stine KC; Vougiouka O; Weaver LK; Davidsone Z; De Inocencio J; Ioseliani M; Lattanzi B; Tezer H; Buoncompagni A; Picco P; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    J Rheumatol; 2015 Jun; 42(6):994-1001. PubMed ID: 25877504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.